Linomet 50/850 mg Tablet
Sitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
MFDS item code 201505827 · Approved 2015.08.20
This product's status changed to Expired on 2025.08.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to assist in blood sugar control for patients with type 2 diabetes. It helps enhance the blood sugar control effect through the combination therapy of sitagliptin and metformin alongside dietary and exercise regimens. Therefore, it is used to maintain blood sugar levels steadily and improve diabetes management.
For antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. This medicine is generally taken twice daily with food. To reduce gastrointestinal adverse reactions caused by metformin, the dose should be increased gradually. The initial dose of this medicine should be determined according to the patient's current treatment regimen. 1. Patients not currently receiving metformin: For patients with no prior experience of antidiabetic drug therapy who do not achieve adequate glycemic control with monotherapy, or for whom sitagliptin monotherapy does not provide adequate glycemic control, the initial dose is 1 tablet of this medicine 50/500 mg twice daily. The dose may be increased to 1 tablet of this medicine 50/1000 mg twice daily. Patients with renal impairment who are receiving a reduced dose of sitagliptin should not be switched to this medicine (see Precautions for Use, 2. Do not administer to the following patients). 2. Patients receiving metformin: - For patients whose glycemic control is inadequate with metformin monotherapy, the recommended initial dose of this medicine is sitagliptin 50 mg twice daily (total daily dose 100 mg) together with the patient's current metformin dose. - Patients switching from combination therapy with sitagliptin and metformin to this medicine may start at their current doses of sitagliptin and metformin. 3. Patients whose glycemic control is inadequate with combination therapy of metformin and a sulfonylurea, metformin and insulin, or metformin and a thiazolidinedione: The initial dose of this medicine is sitagliptin 50 mg twice daily (total daily dose 100 mg). The initial dose of metformin should be determined taking the patient's blood glucose level and current dose into consideration. To reduce gastrointestinal adverse reactions caused by metformin, the dose should be increased gradually. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, 5. General Precautions). Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] ≥ 45 and < 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and < 60 mL/min/1.73m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Treatment should not be initiated with this medicine because the starting dose of metformin is 500 mg or 850 mg once daily. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 mL/min or eGFR < 45 mL/min/1.73m2, this medicine should be discontinued immediately.
This medication is used for the treatment of diabetes, and there are several precautions to consider while taking it. First, there is a risk of serious allergic reactions during treatment, so if symptoms such as skin rashes, breathing difficulties, or swelling of the face or neck occur, the use of the medication should be stopped immediately and a doctor should be consulted. Also, there is a risk of developing pancreatitis, which is inflammation of the pancreas, so if sudden abdominal pain, nausea, vomiting, or fever appear, medical attention should be sought immediately. One of the ingredients in this medication should not be administered to patients with severely impaired kidney function, and if there are any concerns regarding kidney function, the patient must consult a physician before taking this medication. Patients with heart failure or heart disease, or those who have severe infections or dehydration, should also avoid using this medication. Regular kidney function tests and blood tests are important while taking this medication, especially for elderly patients or those with decreased kidney function. Additionally, this medication can cause hypoglycemia, so caution is needed if meals are skipped or if there is a sudden increase in physical activity; the risk of hypoglycemia may increase when taken with other hypoglycemic drugs. Avoiding the use of this medication is advisable if liver function is impaired or if excessive alcohol consumption occurs. Before surgery, this medication should be temporarily discontinued, and it should only be resumed once the patient's condition has stabilized and normal kidney function has been verified after surgery. Women who are pregnant or may become pregnant, and nursing mothers should not take this medication. For children, it is recommended not to use this medication for those under 18 years of age as safety and efficacy have not been established. While taking this medication, side effects such as gastrointestinal disturbances, headache, cold symptoms, and joint pain may occur, and if symptoms are severe or persistent, medical consultation should be sought. Finally, this medication can interact with other drugs, so if the patient is taking other medications, it is crucial to inform healthcare providers, and it is advisable to avoid alcohol consumption before and after taking the medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air from entering and kept at room temperature between 1 degree and 30 degrees Celsius. Storing in this manner will help maintain the medication's efficacy for a longer period.
Pink oval film-coated tablet
28 tablets (14 tablets/PTPX2), 56 tablets (14 tablets/PTPX4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkun Dang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 64.25mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
Jong Kun Dang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication · Combination
JongKeunDang Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Sitagliptin Phosphate 62.04mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Yuyu Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.